A case of Gemella morbillorum native valve endocarditis and results of in vitro susceptibility testing

Farah Tanveer; Joan Pawlak; Dima Youssef; Louis D Saravolatz

doi:10.1016/j.idcr.2021.e01045

A case of Gemella morbillorum native valve endocarditis and results of in vitro susceptibility testing

IDCases. 2021 Jan 9:23:e01045. doi: 10.1016/j.idcr.2021.e01045. eCollection 2021.

Authors

Farah Tanveer¹, Joan Pawlak¹, Dima Youssef¹, Louis D Saravolatz¹

Affiliation

¹ Division of Infectious Disease, Department of Internal Medicine, Ascension St John Hospital, Grosse Pointe Woods, MI, USA.

Abstract

We present a case of a 48 years old male with Gemella morbillorum native mitral valve endocarditis. Due to poor growth of the organism, antimicrobial susceptibility test (AST) could not be performed using the CLSI approved method. AST was determined using Etest© strips and the patient was successfully treated with mitral valve replacement and intravenous ceftriaxone.

Keywords: Antimicrobial susceptibility test; Endocarditis; Gemella morbillorum.

Publication types

Case Reports